Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?
{{output}}
Introduction: The management of inflammatory bowel disease (IBD) has evolved substantially over the past decade, with the emergence of new advanced therapies presenting unprecedented challenges in clinical decision-making. While ... ...
